MX2025010674A - Forma cristalina - Google Patents
Forma cristalinaInfo
- Publication number
- MX2025010674A MX2025010674A MX2025010674A MX2025010674A MX2025010674A MX 2025010674 A MX2025010674 A MX 2025010674A MX 2025010674 A MX2025010674 A MX 2025010674A MX 2025010674 A MX2025010674 A MX 2025010674A MX 2025010674 A MX2025010674 A MX 2025010674A
- Authority
- MX
- Mexico
- Prior art keywords
- crystalline form
- fluoro
- ynyl
- isoindoline
- pyrrolo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente memoria descriptiva se relaciona con una forma cristalina de (3S)-2-[(5-amino-6 fluoro-1H-pirrolo[3,2-b]piridin-2-il)metil]-1'-but-2-inil-6-fluoro-espiro[isoindolina-3,3'-pirrolidina] 1,2'-diona, y con composiciones y usos de esta.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23161547 | 2023-03-13 | ||
| PCT/EP2024/056495 WO2024188999A1 (en) | 2023-03-13 | 2024-03-12 | Crystalline form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2025010674A true MX2025010674A (es) | 2025-10-01 |
Family
ID=85601718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2025010674A MX2025010674A (es) | 2023-03-13 | 2025-09-10 | Forma cristalina |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4680340A1 (es) |
| JP (1) | JP2026508943A (es) |
| KR (1) | KR20250155619A (es) |
| CN (1) | CN120917029A (es) |
| AU (1) | AU2024236796A1 (es) |
| CL (1) | CL2025002744A1 (es) |
| IL (1) | IL323224A (es) |
| MX (1) | MX2025010674A (es) |
| WO (1) | WO2024188999A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20260121A1 (es) | 2023-04-21 | 2026-01-16 | Gilead Sciences Inc | Inhibidores de prmt5 y usos de los mismos |
| WO2026114356A1 (zh) * | 2024-11-29 | 2026-06-04 | 普罗思特(南京)生物科技有限公司 | 含氮杂环化合物及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4304720A1 (en) * | 2021-03-11 | 2024-01-17 | Mirati Therapeutics, Inc. | Mta-cooperative prmt5 inhibitors |
| US20240368153A1 (en) * | 2021-07-02 | 2024-11-07 | Mirati Therapeutics, Inc. | Aminopyridine-based MTA-Cooperative PRMT5 Inhibitors |
| EP4402143A1 (en) | 2021-09-13 | 2024-07-24 | Astrazeneca AB | Spirocyclic compounds |
-
2024
- 2024-03-12 JP JP2025553773A patent/JP2026508943A/ja active Pending
- 2024-03-12 CN CN202480017739.5A patent/CN120917029A/zh active Pending
- 2024-03-12 KR KR1020257033631A patent/KR20250155619A/ko active Pending
- 2024-03-12 EP EP24709774.4A patent/EP4680340A1/en active Pending
- 2024-03-12 WO PCT/EP2024/056495 patent/WO2024188999A1/en not_active Ceased
- 2024-03-12 AU AU2024236796A patent/AU2024236796A1/en active Pending
-
2025
- 2025-09-08 IL IL323224A patent/IL323224A/en unknown
- 2025-09-10 MX MX2025010674A patent/MX2025010674A/es unknown
- 2025-09-10 CL CL2025002744A patent/CL2025002744A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL323224A (en) | 2025-11-01 |
| CL2025002744A1 (es) | 2026-01-02 |
| KR20250155619A (ko) | 2025-10-30 |
| AU2024236796A1 (en) | 2025-10-30 |
| WO2024188999A1 (en) | 2024-09-19 |
| JP2026508943A (ja) | 2026-03-13 |
| EP4680340A1 (en) | 2026-01-21 |
| CN120917029A (zh) | 2025-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2424600A1 (en) | Aliphatic nitrogenous five-membered ring compounds | |
| AU5921394A (en) | HIV protease inhibitors useful for the treatment of AIDS | |
| GEP20063831B (en) | Substituted bicyclic derivatives for treatment of abnormal cell growth | |
| IL172833A0 (en) | Pyrimidine-2,4-dione derivatives and pharmaceutical compositions containing the same | |
| PT1467735E (pt) | Polimorfos de hidrogenossulfato de clopidogrel | |
| DE69915027D1 (de) | Heteroaromatische bizyklische Verbindungen mit Antikrebswirkung | |
| CA2195027A1 (en) | HIV Protease Inhibitors Useful for the Treatment of AIDS | |
| MY124390A (en) | Substituted bicyclic derivatives useful as anticancer agents | |
| GEP20074144B (en) | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | |
| WO2001066534A3 (en) | Cyclic and bicyclic diamino histamine-3 receptor antagonists | |
| IL172834A0 (en) | Pyrimidine-,2,4-dione derivatives and pharmaceutical compositions containing the same | |
| GEP20074210B (en) | Tropane derivatives as ccr5 modulators | |
| MY137969A (en) | Crystal form of asenapine maleate | |
| BR0310057A (pt) | melhoria do desenvolvimento de catarata e outras doenças oftálmicas | |
| WO2006121831A3 (en) | Hiv integrase inhibitors | |
| WO2008006969A3 (fr) | Nouveaux derives tetracycuques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| EP4617276A3 (en) | Pyruvate kinase r (pkr) activating compositions | |
| WO2007083188A3 (en) | Improved process for the preparation of an optically active 5h-pyrrolo [3,4-b] pyrazine derivative | |
| MX2025001384A (es) | Forma cristalina de derivado triciclico fusionado y metodo de preparacion | |
| CL2025002744A1 (es) | Forma cristalina. | |
| GEP20063972B (en) | Streptogramin derivatives, preparation and compositions containing them | |
| EP4545078A3 (en) | Benzo 2-azaspiro[4.4]nonane compound and use thereof | |
| MXPA05008400A (es) | Derivados de oxazolidinona n-sustituidos por un anillo triciclico, para su uso como agentes antibacterianos. | |
| MX2009001141A (es) | Derivados de acido tieno[3,2-c]piridin-2-carboxilico. | |
| MXPA05007937A (es) | Agentes antibacterianos. |